Case Scenario: Self-extraction of Intrathecal Pump Medication with a Concomitant Intrathecal Granulomatous Mass

NTRATHECAL drug delivery systems are used to treat chronic pain and spasticity conditions. One of the first clinical uses of an implantable intrathecal opioid delivery for the management of chronic malignant pain amelioration in to include nonmalignant chronic pain Opioids an infusion agent, the of intrathecal delivery near the site of action within the central nervous system, the therapeutic efficacy, the likelihood of side effects associated with other delivery modalities. The implementation of intrathecal drug delivery pain but or meta-analysis, the potential risks of intrathecal catheters in patients and reported rates of 2.3% (95% and 1.4% (95% for superficial and deep infections, respectively; found to 0.9% (95% CI, 0–2.0) and neurologic injury 0.4% (95% CI, 0–1.0).